{
  "nct_id": "NCT23228919",
  "indication": "Multiple Sclerosis",
  "phase": "Phase 1/2",
  "sample_size": 504,
  "duration_weeks": 56,
  "dropout_rate": 0.42,
  "primary_endpoints": [
    "Relapse rate"
  ],
  "secondary_endpoints": [
    "Relapse rate",
    "EDSS progression"
  ],
  "blinding": "open-label",
  "control_arm": "active comparator",
  "outcome_summary": "Study no significant difference compared to placebo.",
  "success": false,
  "failure_reason": "Endpoint selection issues"
}